RECURSION PHARMACEUTICALS, INC. Quarterly Operating Margin in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Recursion Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q2 2024.
  • Recursion Pharmaceuticals, Inc. Operating Margin for the quarter ending June 30, 2024 was -797 %, a 44.7% decline year-over-year.
  • Recursion Pharmaceuticals, Inc. annual Operating Margin for 2023 was -785 %, a 27.3% decline from 2022.
  • Recursion Pharmaceuticals, Inc. annual Operating Margin for 2022 was -617 %, a 65.7% increase from 2021.
  • Recursion Pharmaceuticals, Inc. annual Operating Margin for 2021 was -1.8K %, a 15.9% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -797 -246 -44.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -814 -258 -46.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -785 -169 -27.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -659 +211 +24.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -550 +742 +57.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -557 +1.05K +65.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -617 +1.18K +65.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -870 +517 +37.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.29K +61.3 +4.53% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.61K -112 -7.45% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.8K +340 +15.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -1.39K Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.35K Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.5K Jan 1, 2021 Mar 31, 2021
Q4 2020 -2.14K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.